Alessandra Latini to Tablets
This is a "connection" page, showing publications Alessandra Latini has written about Tablets.
Connection Strength
0.042
-
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. Antivir Ther. 2018; 23(2):139-148.
Score: 0.042